|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 HKD | 0.00% |
|
+0.53% | +13.10% |
| Mar. 25 | SinoMab BioScience Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 07 | SinoMab BioScience Limited Appoints Shanchun Wang as an Executive Director | CI |
SinoMab BioScience Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1.37 million. Net loss was CNY 243.11 million compared to CNY 284.16 million a year ago.
Basic loss per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago. Diluted loss per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.10% | 265M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
SINOMAB BIOSCIENCE LIMITED 
